Clinical evaluation of twice-daily emedastine 0.05% eye drops (emadine eye drops) versus levocabastine 0.05% eye drops in patients with allergic conjunctivitis

Ph Verin, D. L. Easty, A. Secchi, G. Ciprandi, P. Partouche, G. Nemeth-Wasmer, R. Brancato, C. J. Harrisberg, C. Estivin-Ebrardt, D. J. Coster, A. J G Apel, M. T. Coroneo, M. Knorr, T. R. Carmichael, B. T. Kent-Smith, P. Abrantes, A. Leonardi, P. M. Cerqueti, G. Modorati, M. Martinez

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Clinical evaluation of twice-daily emedastine 0.05% eye drops (emadine eye drops) versus levocabastine 0.05% eye drops in patients with allergic conjunctivitis'. Together they form a unique fingerprint.

Medicine & Life Sciences